Molecular modelling on multiepitope-based vaccine against SARS-CoV-2 using immunoinformatics, molecular docking, and molecular dynamics simulation
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
- Klíčová slova
- MEV, SARS-CoV2, immunoinformatics, in silico, vaccine design,
- MeSH
- COVID-19 * prevence a kontrola MeSH
- epitopy B-lymfocytární chemie genetika MeSH
- epitopy T-lymfocytární chemie genetika MeSH
- imunogenicita vakcíny MeSH
- kvantitativní vztahy mezi strukturou a aktivitou MeSH
- lidé MeSH
- RNA virová MeSH
- SARS-CoV-2 * MeSH
- simulace molekulární dynamiky MeSH
- simulace molekulového dockingu MeSH
- subjednotkové vakcíny chemie MeSH
- vakcíny proti COVID-19 MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- epitopy B-lymfocytární MeSH
- epitopy T-lymfocytární MeSH
- RNA virová MeSH
- subjednotkové vakcíny MeSH
- vakcíny proti COVID-19 MeSH
The pandemic of COVID-19 caused by SARS-CoV-2 has made a worldwide health emergency. Despite the fact that current vaccines are readily available, several SARSCoV-2 variants affecting the existing vaccine are to be less effective due to the mutations in the structural proteins. Furthermore, the appearance of the new variants cannot be easily predicted in the future. Therefore, the attempts to construct new vaccines or to modify the current vaccines are still pivotal works for preventing the spread of the virus. In the present investigation, the computational analysis through immunoinformatics, molecular docking, and molecular dynamics (MD) simulation is employed to construct an effective vaccine against SARS-CoV2. The structural proteins of SARS-CoV2 are utilized to create a multiepitope-based vaccine (MEV). According to our findings presented by systematic procedures in the current investigation, the MEV construct may be able to trigger a strong immunological response against the virus. Therefore, the designed MEV could be a potential vaccine candidate against SARS-CoV-2, and also it is expected to be effective for other variants.
Citace poskytuje Crossref.org
